Apellis Pharmaceuticals, Inc.

PNC FINANCIAL SERVICES GROUP, INC. APLS

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/6/2026

Shares

53,526

Value ($000)

1,345

Weight

0.0%

2019 Q4 - 2025 Q4 (25 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/6/2026	1,345	0.0%	53,526	12/31/2025
2025 Q3	11/7/2025	1,223	0.0%	54,052	9/30/2025
2025 Q2	8/8/2025	1,019	0.0%	58,856	6/30/2025
2025 Q1	5/9/2025	1,277	0.0%	58,391	3/31/2025
2024 Q4	2/7/2025	1,856	0.0%	58,153	12/31/2024
2024 Q3	11/8/2024	1,686	0.0%	58,462	9/30/2024
2024 Q2	8/9/2024	2,267	0.0%	59,088	6/30/2024
2024 Q1	5/10/2024	3,445	0.0%	58,610	3/31/2024
2023 Q4	3/22/2024	7,170	0.0%	119,785	12/31/2023
2023 Q3	11/13/2023	4,555	0.0%	119,740	9/30/2023
2023 Q2	8/11/2023	11,146	0.0%	122,351	6/30/2023
2023 Q1	5/15/2023	4,054	0.0%	61,465	3/31/2023
2022 Q4	2/10/2023	3,152	0.0%	60,955	12/31/2022
2022 Q3	11/10/2022	3,958	0.0%	57,946	9/30/2022
2022 Q2	8/12/2022	2,612	0.0%	57,752	6/30/2022
2022 Q1	5/12/2022	2,932	0.0%	57,699	3/31/2022
2021 Q4	2/11/2022	612	0.0%	12,948	12/31/2021
2021 Q3	11/5/2021	200	0.0%	6,058	9/30/2021
2021 Q2	8/6/2021	376	0.0%	5,948	6/30/2021
2021 Q1	5/7/2021	255	0.0%	5,948	3/31/2021
2020 Q4	2/12/2021	340	0.0%	5,948	12/31/2020
2020 Q3	11/6/2020	179	0.0%	5,948	9/30/2020
2020 Q2	8/28/2020	164	0.0%	5,008	6/30/2020
2020 Q1	5/8/2020	134	0.0%	5,000	3/31/2020
2019 Q4	2/7/2020	154	0.0%	5,000	12/31/2019